167 research outputs found
P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
Low-temperature solution synthesis of chemically functional ferromagnetic FePtAu nanoparticles
Magnetic nanoparticles are of great scientific and technological interest. The application of ferromagnetic nanoparticles for high-density data storage has great potential, but energy efficient synthesis of uniform, isolated, and patternable nanoparticles that remain ferromagnetic at room temperature is not trivial. Here, we present a low-temperature solution synthesis method for FePtAu nanoparticles that addresses all those issues and therefore can be regarded as an important step toward applications. We show that the onset of the chemically ordered face-centered tetragonal (L10) phase is obtained for thermal annealing temperatures as low as 150 C. Large uniaxial magnetic anisotropy (107 erg/cm3) and a high long-range order parameter have been obtained. Our low-temperature solution annealing leaves the organic ligands intact, so that the possibility for postanneal monolayer formation and chemically assisted patterning on a surface is maintained
Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon
<p>Abstract</p> <p>Background</p> <p>In 2002, Cameroon initiated scale up of antiretroviral therapy (ART); on 1 October 2004, a substantial reduction in ART cost occurred. We assessed the impact of this event and other factors on enrolment and retention in care among HIV-infected patients initiating ART from February 2002 to December 2005 at the single ART clinic serving the Southwest Region in Limbe, Cameroon.</p> <p>Methods</p> <p>We retrospectively analyzed clinical and pharmacy payment records of HIV-infected patients initiating ART according to national guidelines. We compared two cohorts of patients, enrolled before and after 1 October 2004, to determine if price reduction was associated with enhanced enrolment. We assessed factors associated with retention and survival by Cox proportional hazards models. Retention in care implied patients who had contact with the healthcare system as of 31 December 2005 (including those who were transferred to continue care in other ART centres), although these patients may have interrupted therapy at some time. A patient who was not retained in care may have dropped out (lost to follow up) or died.</p> <p>Results</p> <p>Mean enrolment rates for 2920 patients who initiated ART before and after the price reduction were 46.5 and 95.5 persons/month, respectively (p < 0.001). The probabilities of remaining alive and in care were 0.66 (95% CI 0.64-0.68) at six months, 0.58 (95% CI 0.56-0.60) at one year, 0.47 (95% CI 0.45-0.49) at two years and 0.35 (95% CI 0.32-0.38) at three years; they were not significantly different between the two cohorts of patients enrolled before and after the price reduction over the first 15 months of comparable follow up (hazard ratio 1.1; 95% CI 0.9-1.2, p = 0.27). In multivariable analysis using multiple imputations to compensate for missing values, factors associated with dropping out of care or dying were male gender (HR 1.33 [1.18-1.50], p = 0.003), treatment paid by self, family or partly by other (HR 3.05 [1.99-4.67], p < 0.001), and, compared with residents of Limbe, living more than 150 km from Limbe (HR 1.41 [1.18-1.69], p < 0.001), or being residents of Douala (HR 1.51 [1.16-1.98], p < 0.001).</p> <p>Conclusions</p> <p>Reducing the cost of ART increased enrolment of clients in the programme, but did not change retention in care. In a system where most clients pay for ART, an accessible clinic location may be more important than the cost of medication for retention in care. Decentralizing ART clinics might improve retention and survival among patients on ART.</p
Factors associated with an interruption in treatment of people living with HIV in USAID-supported states in Nigeria : a retrospective study from 2000â2020
BACKGROUND : Patient interruption of antiretroviral therapy (ART) continues to limit HIV programsâ progress toward
epidemic control. Multiple factors have been associated with client interruption in treatment (IIT)â including age,
gender, CD4 count, and education level. In this paper, we explore the factors associated with IIT in people living with
HIV (PLHIV) in United States Agency for International Development (USAID)-supported facilities under the U.S. Presidentâs
Emergency Plan for AIDS Relief (PEPFAR) program in Nigeria.
METHODS : We conducted cross-sectional analyses on data obtained from Nigeriaâs National Data Repository (NDR),
representing a summarized record of 573 630 ART clients that received care at 484 PEPFAR/USAID-supported facilities
in 16 states from 2000â2020. IIT was defined as no clinical contact for 28 days or more after the last expected clinical
contact. Univariate and multivariate logistic regression models were computed to explore the factors associated with
IIT. The variables included in the analysis were sex, age group, zone, facility level, regimen line, multi-month dispensing
(MMD), and viral load category.
RESULTS : Of the 573 630 clients analysed in this study, 32% have been recorded as having interrupted treatment. Of
the clients investigated, 66% were female (32% had interrupted treatment), 39% were aged 25â34 at their last ART
pick-up date (with 32% of them interrupted treatment), 59% received care at secondary level facilities (37% interrupted
treatment) and 38% were last receiving between three- to five-month MMD (with 10% of these interrupted
treatment). Those less likely to interrupt ART were males (aOR = 0.91), clients on six-month MMD (aOR = 0.01), adults
on 2nd
line regimen (aOR = 0.09), and paediatrics on salvage regimen (aOR = 0.02). Clients most likely to interrupt ART
were located in the South West Zone (aOR = 1.99), received treatment at a tertiary level (aOR = 12.34) or secondary
level facilities (aOR = 4.01), and had no viral load (VL) on record (aOR =10.02). Age group was not significantly associated
with IIT.
CONCLUSIONS : Sex, zone, facility level, regimen line, MMD, and VL were significantly associated with IIT. MMD of three
months and longer (especially six months) had better retention on ART than those on shorter MMD. Not having a VL
on record was associated with a considerable risk of IIT.https://bmcpublichealth.biomedcentral.comam2022Human Nutritio
Musculoskeletal disorders in Norway: prevalence of chronicity and use of primary and specialist health care services
Comparison of the Swedish STarT Back Screening Tool and the Short Form of the Ărebro Musculoskeletal Pain Screening Questionnaire in patients with acute or subacute back and neck pain
Evolution and patterns of global health financing 1995-2014 : development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
Background An adequate amount of prepaid resources for health is important to ensure access to health services and for the pursuit of universal health coverage. Previous studies on global health financing have described the relationship between economic development and health financing. In this study, we further explore global health financing trends and examine how the sources of funds used, types of services purchased, and development assistance for health disbursed change with economic development. We also identify countries that deviate from the trends. Methods We estimated national health spending by type of care and by source, including development assistance for health, based on a diverse set of data including programme reports, budget data, national estimates, and 964 National Health Accounts. These data represent health spending for 184 countries from 1995 through 2014. We converted these data into a common inflation-adjusted and purchasing power-adjusted currency, and used non-linear regression methods to model the relationship between health financing, time, and economic development. Findings Between 1995 and 2014, economic development was positively associated with total health spending and a shift away from a reliance on development assistance and out-of-pocket (OOP) towards government spending. The largest absolute increase in spending was in high-income countries, which increased to purchasing power-adjusted 914 and 51 to 37.6 billion in 2016. Nonetheless, there is a great deal of variation revolving around these averages. 29 countries spend at least 50% more than expected per capita, based on their level of economic development alone, whereas 11 countries spend less than 50% their expected amount. Interpretation Health spending remains disparate, with low-income and lower-middle-income countries increasing spending in absolute terms the least, and relying heavily on OOP spending and development assistance. Moreover, tremendous variation shows that neither time nor economic development guarantee adequate prepaid health resources, which are vital for the pursuit of universal health coverage.Peer reviewe
Photogeneration and Mobility of Charge Carriers in Atomically Thin Colloidal InSe Nanosheets Probed by Ultrafast Terahertz Spectroscopy
Future and potential spending on health 2015-40: Development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
Background: The amount of resources, particularly prepaid resources, available for health can affect access to health care and health outcomes. Although health spending tends to increase with economic development, tremendous variation exists among health financing systems. Estimates of future spending can be beneficial for policy makers and planners, and can identify financing gaps. In this study, we estimate future gross domestic product (GDP), all-sector government spending, and health spending disaggregated by source, and we compare expected future spending to potential future spending. Methods: We extracted GDP, government spending in 184 countries from 1980-2015, and health spend data from 1995-2014. We used a series of ensemble models to estimate future GDP, all-sector government spending, development assistance for health, and government, out-of-pocket, and prepaid private health spending through 2040. We used frontier analyses to identify patterns exhibited by the countries that dedicate the most funding to health, and used these frontiers to estimate potential health spending for each low-income or middle-income country. All estimates are inflation and purchasing power adjusted. Findings: We estimated that global spending on health will increase from US24.24 trillion (uncertainty interval [UI] 20.47-29.72) in 2040. We expect per capita health spending to increase fastest in upper-middle-income countries, at 5.3% (UI 4.1-6.8) per year. This growth is driven by continued growth in GDP, government spending, and government health spending. Lower-middle income countries are expected to grow at 4.2% (3.8-4.9). High-income countries are expected to grow at 2.1% (UI 1.8-2.4) and low-income countries are expected to grow at 1.8% (1.0-2.8). Despite this growth, health spending per capita in low-income countries is expected to remain low, at 195 (157-258) per capita in 2040. Increases in national health spending to reach the level of the countries who spend the most on health, relative to their level of economic development, would mean $321 (157-258) per capita was available for health in 2040 in low-income countries. Interpretation: Health spending is associated with economic development but past trends and relationships suggest that spending will remain variable, and low in some low-resource settings. Policy change could lead to increased health spending, although for the poorest countries external support might remain essential
Directed Self-Assembly: Expectations and Achievements
Nanotechnology has been a revolutionary thrust in recent years of development of science and technology for its broad appeal for employing a novel idea for relevant technological applications in particular and for mass-scale production and marketing as common man commodity in general. An interesting aspect of this emergent technology is that it involves scientific research community and relevant industries alike. Topâdown and bottomâup approaches are two broad division of production of nanoscale materials in general. However, both the approaches have their own limits as far as large-scale production and cost involved are concerned. Therefore, novel new techniques are desired to be developed to optimize production and cost. Directed self-assembly seems to be a promising technique in this regard; which can work as a bridge between the topâdown and bottomâup approaches. This article reviews how directed self-assembly as a technique has grown up and outlines its future prospects
- âŠ